Malignant melanoma: clinical variants and prognostic indicators.
作者： R. M. MacKie
DOI: 10.1046/J.1365-2230.2000.00692.X
关键词: Melanoma 、 Molecular marker 、 Pathology 、 Research setting 、 Medicine 、 Pathological
摘要: The four main clinicopathological subsets of melanoma are described and the arguments for their retention in a research setting presented. Further additional described, including partly regressed primary melanoma, arising congenital naevus multiple tumours. Pathological prognostic indicators discussed pre-eminent significance tumour thickness its interaction with ulceration described. need accurate personal predictive profiles as distinct from those relevant to populations is discussed, molecular marker metastatic potential.
sci-hub.se 参考文章(19)
M Keefe, , RM Mackie, The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group. British Journal of Cancer. ,vol. 64, pp. 598- 602 ,(1991) , 10.1038/BJC.1991.357
R. M MacKie, D. Hole, J. A A Hunter, R. Rankin, A. Evans, K. McLaren, M. Fallowfield, A. Hutcheon, A. Morris, Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ. ,vol. 315, pp. 1117- 1121 ,(1997) , 10.1136/BMJ.315.7116.1117
NH Cox, , TC Aitchison, JM Sirel, RM MacKie, Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group. British Journal of Cancer. ,vol. 73, pp. 940- 944 ,(1996) , 10.1038/BJC.1996.168
Ann J. Worth, Richard P. Gallagher, J. Mark Elwood, Paul C. Yang, Charles Lamb, John J. Spinelli, William S. Wood, William J. Threlfall, Gerry B. Hill, Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study. International Journal of Cancer. ,vol. 43, pp. 370- 375 ,(1989) , 10.1002/IJC.2910430303
Claus Garbe, Petra Büttner, Jochen Bertz, Günter Burg, Barbara d'Hoedt, Hubert Drepper, Irene Guggenmoos-Holzmann, Walter Lechner, Andrea Lippold, Constantin E. Orfanos, Almut Peters, Gernot Rassner, Rudolf Stadler, Waltraud Stroebel, Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients Cancer. ,vol. 75, pp. 2484- 2491 ,(1995) , 10.1002/1097-0142(19950515)75:10<2484::AID-CNCR2820751014>3.0.CO;2-U
John W. Kelly, Richard W. Sagebiel, Marsden S. Blois, Regression in malignant melanoma. A histologic feature without independent prognostic significance Cancer. ,vol. 56, pp. 2287- 2291 ,(1985) , 10.1002/1097-0142(19851101)56:9<2287::AID-CNCR2820560924>3.0.CO;2-Y
Boel K. Ragnarsson-Olding, Lena R. Kanter-Lewensohn, Bengt Lagerl�f, Bo R. Nilsson, Ulrik K. Ringborg, Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features. Cancer. ,vol. 86, pp. 1273- 1284 ,(1999) , 10.1002/(SICI)1097-0142(19991001)86:7<1273::AID-CNCR24>3.0.CO;2-Z
Alfred W. Kopf, Dennis F. Gross, Gary S. Rogers, Darrell S. Rigel, Laura J. Hellman, Marcia Levenstein, Bruce Welkovich, Robert J. Friedman, Daniel F. Roses, Robert S. Bart, Medwin M. Mintzis, Stephen L. Gumport, Prognostic index for malignant melanoma Cancer. ,vol. 59, pp. 1236- 1241 ,(1987) , 10.1002/1097-0142(19870315)59:6<1236::AID-CNCR2820590634>3.0.CO;2-I
Eva Månsson-Brahme, John Carstensen, Kerstin Erhardt, Bengt Lagerlöf, Ulrik Ringborg, Lars Erik Rutqvist, Prognostic factors in thin cutaneous malignant melanoma. Cancer. ,vol. 73, pp. 2324- 2332 ,(1994) , 10.1002/1097-0142(19940501)73:9<2324::AID-CNCR2820730914>3.0.CO;2-5
Paul F. Austin, C. Wayne Cruse, Gary Lyman, Kenneth Schroer, Frank Glass, Douglas S. Reintgen, Age as a prognostic factor in the malignant melanoma population Annals of Surgical Oncology. ,vol. 1, pp. 487- 494 ,(1994) , 10.1007/BF02303614